[ad_1]
Updated Dec 13, 2023, 12:47 pm EST / Original Dec 13, 2023, 7:08 am EST
Share
Reprints
Pfizer on Wednesday released financial guidance for 2024 that is billions of dollars short of what investors had anticipated, raising questions about the company’s strategy and sending shares lower than they had closed in a decade.
Continue reading this article with a Barron’s subscription.
[ad_2]